Clinical drug evaluation using imaging readouts: regulatory perspectives
- 1 January 2005
- book chapter
- Published by Springer Nature
- Vol. 62, 357-384
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disordersTrends in Pharmacological Sciences, 2005
- Bioinformatics and cancer target discoveryDrug Discovery Today, 2004
- Target discovery in metabolic diseaseDrug Discovery Today, 2004
- Diagnostic criteria for multiple sclerosis: an historical reviewClinical Neurology and Neurosurgery, 2004
- Evaluation of the response to treatment of solid tumours – a consensus statement of the International Cancer Imaging SocietyBritish Journal of Cancer, 2004
- A statistical simulation study finds discordance between WHO criteria and RECIST guidelineJournal of Clinical Epidemiology, 2004
- MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN β-1bNeurology, 2003
- The RECIST criteria: implications for diagnostic radiologistsBritish Journal of Radiology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960